Systematic Review and Meta-Analysis of Venous Thromboembolism (VTE) Risk Assessment in Hospitalized Medical Patients
Recruiting in Palo Alto (17 mi)
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Intermountain Health Care, Inc.
No Placebo Group
Trial Summary
What is the purpose of this trial?A systematic review and meta analysis will be performed of risk assessment models for Venous thromboembolism ("VTE" including pulmonary embolism "PE" and deep venous thrombosis "DVT")in hospitalized medical patients. The goal of this study is to evaluate whether the incidence of VTE is lower in patients that are evaluated with a risk assessment model and treated with thromboprophylaxis for their assigned level of risk.
Eligibility Criteria
Inclusion Criteria
Adults
Hospitalized
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Hospitalized Medical PatientsExperimental Treatment1 Intervention
All hospitalized medical adult patients
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Intermountain Medical CenterMurray, UT
Loading ...
Who Is Running the Clinical Trial?
Intermountain Health Care, Inc.Lead Sponsor